Differential effects of paroxetine on raphe and cortical 5-HT1A binding: A PET study in monkeys

NeuroImage

Volumn 28, Issue 1, 2005, Pages 238-248

  Giovacchini, Giampiero ^a,b   Lang, Lixin ^a   Ma, Ying ^a   Herscovitch, Peter ^a   Eckelman, William C ^a   Carson, Richard E ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT; Paroxetine; Positron emission tomography

Indexed keywords

4 FLUORO N [2 [4 (2 METHOXYPHENYL)PIPERAZIN 1 YL]ETHYL] N PYRIMIDIN 2 YLBENZAMIDE; BENZAMIDE DERIVATIVE; CARBON 11; FLUORODEOXYGLUCOSE F 18; PAROXETINE; RADIOISOTOPE; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BINDING SITE; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; IMAGE ANALYSIS; LIGAND BINDING; MICRODIALYSIS; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; RECEPTOR SENSITIVITY; RHESUS MONKEY; SEROTONIN UPTAKE; SEROTONINERGIC NERVE CELL;

ANIMALS; CEREBRAL CORTEX; IMAGE PROCESSING, COMPUTER-ASSISTED; INFUSIONS, INTRAVENOUS; MACACA MULATTA; MICRODIALYSIS; PAROXETINE; POSITRON-EMISSION TOMOGRAPHY; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 25844463424     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2005.05.042     Document Type: Article

References (91)

1. A. Adell, and F. Artigas Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study Naunyn-Schmiedeberg's Arch. Pharmacol. 343 1991 237 244
2. A. Adell, and F. Artigas Effects of clomipramine on extracellular serotonin in the rat frontal cortex Adv. Exp. Med. Biol. 294 1991 451 454
3. A. Adell, A. Carceller, and F. Artigas In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin J. Neurochem. 60 1993 1673 1681
4. G.K. Aghajanian, and I.M. Asher Histochemical fluorescence of raphe neurons: selective enhancement by tryptophan Science 172 1971 1159 1161
5. G.K. Aghajanian, and F.E. Bloom Localization of tritiated serotonin in rat brain by electron-microscopic autoradiography J. Pharmacol. Exp. Ther. 156 1967 23 30
6. N. Bel, and F. Artigas Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study Eur. J. Pharmacol. 229 1992 101 103
7. 1A agonist gepirone: electrophysiological studies in the rat brain Synapse 1 1987 470 480
8. P. Blier, and C. de Montigny Current advances and trends in the treatment of depression Trends Pharmacol. Sci. 15 1994 220 226
9. P.M. Bloomfield, T.J. Spinks, J. Reed, L. Schnorr, A.M. Westrip, L. Livieratos, R. Fulton, and T. Jones The design and implementation of a motion correction scheme for neurological PET Phys. Med. Biol. 48 2003 959 978
10. A. Breier, T.P. Su, R. Saunders, R.E. Carson, B.S. Kolachana, A. de Bartolomeis, D.R. Weinberger, N. Weisenfeld, A.K. Malhotra, W.C. Eckelman, and D. Pickar Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method Proc. Natl. Acad. Sci. U. S. A. 94 1997 2569 2574
11. R.E. Carson PET physiological measurements using constant infusion Nucl. Med. Biol. 27 2000 657 660
12. 18F]cyclofoxy and positron emission tomography J. Cereb. Blood Flow Metab. 13 1993 24 42
13. 1A antagonists with intermediate affinity J. Nucl. Med. 42 2001 106 p.
14. Y. Chaput, P. Blier, and C. de Montigny In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals J. Neurosci. 6 1986 2796 2801
15. 2A receptor in the central nervous system of adult rat J. Comp. Neurol. 409 1999 187 209
16. 3H] paroxetine in the rat brain Synapse 15 1993 124 129
17. 18F]MPPF binding Synapse 46 2002 108 115
18. C. de Montigny, and P. Blier Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers Arch. Gen. Psychiatry 48 1991 483 484
19. S.L. Dewey, G.S. Smith, J. Logan, J.D. Brodie, P. Simkowitz, R.R. MacGregor, J.S. Fowler, N.D. Volkow, and A.P. Wolf Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects Proc. Natl. Acad. Sci. U. S. A. 90 1993 11816 11820
20. W.C. Eckelman Sensitivity of new radiopharmaceuticals Nucl. Med. Biol. 25 1998 169 173
21. C.J. Endres, and R.E. Carson Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands J. Cereb. Blood Flow Metab. 18 1998 1196 1210
22. 11C] raclopride: combined PET-microdialysis studies J. Cereb. Blood Flow Metab. 17 1997 932 942
23. 11C]raclopride Arch. Gen. Psychiatry 47 1990 213 219
24. 1A receptors in the primate brain Psychopharmacology (Berlin) 133 1997 196 202
25. 3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems Proc. Natl. Acad. Sci. U. S. A. 80 1983 3836 3840
26. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT Br. J. Pharmacol. 115 1995 1064 1070
27. 1A autoreceptors and noradrenergic mechanisms Psychopharmacology (Berlin) 130 1997 261 268
28. S.E. Gartside, E.M. Clifford, P.J. Cowen, and T. Sharp Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study Br. J. Pharmacol. 127 1999 145 152
29. 11C]-DASB binding to the human serotonin transporter: modeling strategies J. Cereb. Blood Flow Metab. 21 2001 1342 1353
30. 11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats Synapse 47 2003 123 133
31. 11C]WAY-100635 for PET NeuroImage 8 1998 426 440
32. 11C]WAY-100635 PET studies Nucl. Med. Biol. 27 2000 477 482
33. 1A receptor A. Gjedde S.B. Hansen G.M. Knudsen O.B. Paulson Physiological Imaging of the Brain with PET 2001 Academic Press San Diego, CA 171 176
34. M. Hajos, S.E. Gartside, and T. Sharp Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine Naunyn-Schmiedeberg's Arch. Pharmacol. 351 1995 624 629
35. 11C]way-100635 Brain Res. 745 1997 96 108
36. 11C]M100907 Synapse 38 2000 421 431
37. 15O. I. Theory and error analysis J. Nucl. Med. 24 1983 782 789
38. I. Hervas, and F. Artigas Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors Eur. J. Pharmacol. 358 1998 9 18
39. F. Hery, S. Bourgoin, M. Hamon, J.P. Ternaux, and J. Glowinski Control of the release of newly synthetized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices Naunyn-Schmiedeberg's Arch. Pharmacol. 296 1977 91 97
40. 1A receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635 Synapse 36 2000 330 341
41. 11C]MDL 100907: small animal PET and gene expression studies Synapse 50 2003 251 260
42. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study J. Neurochem. 60 1993 776 779
43. 1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI) Behav. Brain Res. 73 1996 281 283
44. S.P. Hume, R.N. Gunn, and T. Jones Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals Eur. J. Nucl. Med. 25 1998 173 176
45. 1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine Synapse 41 2001 150 159
46. R. Invernizzi, S. Belli, and R. Samanin Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex Brain Res. 584 1992 322 324
47. A.A. Lammertsma, and S.P. Hume Simplified reference tissue model for PET receptor studies NeuroImage 4 1996 153 158
48. 1A antagonists J. Med. Chem. 42 1999 1576 1586
49. L. Lang, E. Jagoda, B. Schmall, M. Sassaman, Y. Ma, and W.C. Eckelman Fluoro analogs of WAY-100635 with varying pharmacokinetics properties Nucl. Med. Biol. 27 2000 457 462
50. M. Laruelle Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review J. Cereb. Blood Flow Metab. 20 2000 423 451
51. M. Laruelle, A. Abi-Dargham, C.H. van Dyck, R. Gil, C.D. D'Souza, J. Erdos, E. McCance, W. Rosenblatt, C. Fingado, S.S. Zoghbi, R.M. Baldwin, J.P. Seibyl, J.H. Krystal, D.S. Charney, and R.B. Innis Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc. Natl. Acad. Sci. U. S. A. 93 1996 9235 9240
52. M. Laruelle, R.N. Iyer, M.S. al-Tikriti, Y. Zea-Ponce, R. Malison, S.S. Zoghbi, R.M. Baldwin, H.F. Kung, D.S. Charney, P.B. Hoffer, R.B. Innis, and C.W. Bradberry Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates Synapse 25 1997 1 14
53. M. Laruelle, A. Abi-Dargham, R. Gil, L. Kegeles, and R. Innis Increased dopamine transmission in schizophrenia: relationship to illness phases Biol. Psychiatry 46 1999 56 72
54. 1A antagonists, N-[2-[4-(2-methoxylphenyl) piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes J. Chromatogr., B: Biomed. Sci. Appl. 755 2001 47 56
55. 11C]WAY-100635: effect of endogenous serotonin Synapse 40 2001 122 129
56. I. Malagie, A.C. Trillat, C. Jacquot, and A.M. Gardier Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study Eur. J. Pharmacol. 286 1995 213 217
57. I. Malagie, A.C. Trillat, E. Douvier, M.C. Anmella, M.C. Dessalles, C. Jacquot, and A.M. Gardier Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study Naunyn-Schmiedeberg's Arch. Pharmacol. 354 1996 785 790
58. 3H]serotonin release in different rat brain areas Eur. J. Pharmacol. 129 1986 353 357
59. 1A receptor antagonist J. Nucl. Med. 36 1995 Suppl 162 p.
60. 11C]DASB PET imaging study Am. J. Psychiatry 158 2001 1843 1849
61. 11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency Biol. Psychiatry 57 2005 102 106
62. M.A. Mintun, M.E. Raichle, M.R. Kilbourn, G.F. Wooten, and M.J. Welch A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography Ann. Neurol. 15 1984 217 227
63. 11C]carbonyl-WAY 100635 and endogenous serotonin J. Nucl. Med. 40 1997 167 p.
64. 11C]carbonyl-WAY 100635 and endogenous serotonin J. Nucl. Med. 40 1999 Suppl. 29 p.
65. 11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions J. Cereb. Blood Flow Metab. 20 2000 1111 1133
66. 18F]MPPF J. Nucl. Med. 41 2000 1830 1835
67. 2A receptors is unaltered after citalopram and pindolol challenge J. Cereb. Blood Flow Metab. 24 2004 1037 1045
68. 18F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons Synapse 41 2001 1 10
69. 1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables NeuroImage 15 2002 620 632
70. 18F]-MPPF by the electrically evoked serotonin release in the rat hippocampus Synapse 49 2003 239 245
71. M. Riad, K.C. Watkins, E. Doucet, M. Hamon, and L. Descarries Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors) J. Neurosci. 21 2001 8378 8386
72. 18F]MPPF in the nucleus raphe dorsalis of rat J. Neurosci. 24 2004 5420 5426
73. O.V. Rice, S.J. Gatley, J. Shen, C.L. Huemmer, R. Rogoz, O.T. DeJesus, N.D. Volkow, and A.N. Gifford Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice Neuropsychopharmacology 25 2001 679 689
74. 1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors J. Neurochem. 68 1997 2593 2603
75. J.J. Rutter, C. Gundlah, and S.B. Auerbach Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation Synapse 20 1995 225 233
76. T. Sharp, S.R. Bramwell, D. Clark, and D.G. Grahame-Smith In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity J. Neurochem. 53 1989 234 240
77. 1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo Br. J. Pharmacol. 121 1997 941 946
78. 1A selective agonists Eur. J. Pharmacol. 128 1986 295 298
79. J.S. Sprouse, C.W. Bradberry, R.H. Roth, and G.K. Aghajanian MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin Eur. J. Pharmacol. 167 1989 375 383
80. 18F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies Nucl. Med. Biol. 28 2001 271 279
81. 11C]DASB as serotonin transporter radioligands under various experimental conditions J. Nucl. Med. 43 2002 678 692
82. 11C]DASB in healthy humans Synapse 55 2004 164 175
83. D.R. Thomas, D.R. Nelson, and A.M. Johnson Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor Psychopharmacology (Berlin) 93 1987 193 200
84. 1A receptor binding in patients with temporal lobe epilepsy Neurology 60 2003 749 756
85. 11C]MDL 100,907 J. Cereb. Blood Flow Metab. 20 2000 899 909
86. K. Wienhard, M. Schmand, M.E. Casey, K. Baker, J. Bao, L. Eriksson, W.F. Jones, C. Knoess, M. Lenox, M. Lercher, P. Luk, C. Michel, J.H. Reed, N. Richerzhagen, J. Treffert, S. Vollmar, J.W. Young, W.D. Heiss, and R. Nutt The ECAT HRRT: performance and first clinical application of the new high resolution research tomograph IEEE Trans. Nucl. Sci. 49 2002 104 110
87. 11C]-labeled 2-(phenylthio)araalkylamines J. Med. Chem. 43 2000 3103 3110
88. R.P. Woods, J.C. Mazziotta, and S.R. Cherry MRI-PET registration with automated algorithm J. Comput. Assist. Tomogr. 17 1993 536 546
89. 18F]MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis J. Neurochem. 80 2002 278 286
90. 18F]MPPF binding in the rat dorsal raphe nucleus Eur. J. Nucl. Med. Mol. Imaging 29 2002 1237 1247
91. 18F]MPPF binding in the rat hippocampus J. Nucl. Med. 44 2003 1495 1501